SHINE Medical Technologies, Inc.; SHINE Medical Isotope Facility, 11600-11601 [2016-04864]

Download as PDF 11600 Federal Register / Vol. 81, No. 43 / Friday, March 4, 2016 / Notices unrestricted use under subpart E requirements. jstallworth on DSK7TPTVN1PROD with NOTICES Agencies and Persons Consulted In accordance with its stated policy, the NRC consulted with the Utah Department of Environmental Quality, Division of Waste Management and Radiation Control, regarding the environmental assessment and safety evaluation impacts of the proposed action (ADAMS Accession No. ML15338A187). On January 6, 2016, the State agency informed the NRC that it had no comments on the proposed action (ADAMS Accession No. ML16008B076). As part of its 2014 environmental assessment process for the overhaul complex, the Air Force consulted with local Tribes and the Utah Division of State History. The Air Force provided documentation of their responses as attachments to its EA. The Utah Division of State History and the Hopi Tribe concurred with the finding of no adverse impacts, and the Navajo Nation concluded that the proposed project would not have an impact on Navajo traditional cultural properties (ADAMS Accession Nos. ML15282A470 and ML15282A476). The NRC staff did not consult with these State and tribal entities, due to the results of the Air Force’s consultations. The NRC staff determined that the proposed action will not affect listed species or critical habitats based on the results of previous consultations provided by the Air Force to the NRC. Therefore, no further consultations are required under Section 7 of the Endangered Species Act. Likewise, the NRC staff determined that the proposed action is not the type of activity that has the potential to cause effects on historic properties, in part, because there are no structures located at or adjacent to Site WR–111. Therefore, no further consultation is required under Section 106 of the National Historic Preservation Act. III. Finding of No Significant Impact The NRC staff concluded that the proposed decommissioning project at Site WR–111 at Hill Air Force Base, Utah, will have a minimal impact on the environment. The NRC staff considered air quality, solid and hazardous wastes, biological resources, water quality, cultural resources, and worker safety. In addition, the staff determined that the affected environment and the environmental impacts associated with the decommissioning of Site WR–111 are bounded by the impacts evaluated by NUREG–1496, ‘‘Generic Environmental Impact Statement in VerDate Sep<11>2014 15:22 Mar 03, 2016 Jkt 238001 Support of Rulemaking on Radiological Criteria for License Termination of NRCLicensed Nuclear Facilities’’ (ADAMS Accession No. ML042310492). Based on the analysis contained in this EA, the NRC staff concludes that the proposed action will not have a significant effect on the quality of the human environment and has determined not to prepare an environmental impact statement for the proposed action. Accordingly, the NRC has determined that a Finding of No Significant Impact (FONSI) is appropriate. Dated at Arlington, Texas, this 17th day of February 2016. For the Nuclear Regulatory Commission. Jack E. Whitten, Chief, Nuclear Materials Safety Branch B, Division of Nuclear Materials Safety, Region IV Office. [FR Doc. 2016–04863 Filed 3–3–16; 8:45 am] BILLING CODE 7590–01–P adams.html. To begin the search, select ‘‘ADAMS Public Documents’’ and then select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301–415–4737, or by email to pdr.resource@nrc.gov. For the convenience of the reader, the ADAMS accession numbers are provided in a table in the ‘‘Availability of Documents’’ section of this document. • NRC’s PDR: You may examine and purchase copies of public documents at the NRC’s PDR, Room O1–F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. FOR FURTHER INFORMATION CONTACT: Steven Lynch, Office of Nuclear Reactor Regulation, U.S. Nuclear Regulatory Commission, Washington, DC 20555– 0001; telephone: 301–415–1524, email: Steven.Lynch@nrc.gov. SUPPLEMENTARY INFORMATION: I. Introduction NUCLEAR REGULATORY COMMISSION [Docket No. 50–608; NRC–2013–0053] SHINE Medical Technologies, Inc.; SHINE Medical Isotope Facility Nuclear Regulatory Commission. ACTION: Construction permit and record of decision; issuance. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) is providing notice of the issuance of Construction Permit CPMIF–001 to SHINE Medical Technologies, Inc. (SHINE) and record of decision, located in Janesville, Wisconsin. SUMMARY: Please refer to Docket ID NRC–2013–0053 when contacting the NRC about the availability of information regarding this document. You may obtain publicly-available information related to this document using any of the following methods: • Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC–2013–0053. Address questions about NRC dockets to Carol Gallagher; telephone: 301–415–3463; email: Carol.Gallagher@nrc.gov. For technical questions, contact the individual listed in the FOR FURTHER INFORMATION CONTACT section of this document. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publiclyavailable documents online in the ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/ ADDRESSES: PO 00000 Frm 00093 Fmt 4703 Sfmt 4703 Under section 2.106 of title 10 of the Code of Federal Regulations (10 CFR), the NRC is providing notice of the issuance of Construction Permit, CPMIF–001 to SHINE and, issuance of the Record of Decision (ROD) under 10 CFR 51.102(c). The construction permit, which is immediately effective, authorizes SHINE to construct a facility that will house eight utilization facilities and one production facility designed for the production of medical radioisotopes, as described in SHINE’s application for construction permit, in Janesville, Wisconsin. With respect to the application for the construction permit filed by SHINE, the NRC finds that the applicable standards and requirements of the Atomic Energy Act of 1954, as amended (the Act), and the Commission’s regulations have been met. The NRC finds that any required notifications to other agencies or bodies have been duly made and that, among other things, there is reasonable assurance that the activities authorized by the permit will be conducted in compliance with the rules and regulations of the Commission, that safety questions will be satisfactorily resolved by the completion of construction, and that, taking into consideration siting criteria, the proposed facility can be constructed and operated at the proposed location without under risk to public health and safety, subject to the conditions listed in the construction permit. Furthermore, the NRC finds that the licensee is technically and financially qualified to engage in the activities authorized, and that issuance of the license will not be E:\FR\FM\04MRN1.SGM 04MRN1 11601 Federal Register / Vol. 81, No. 43 / Friday, March 4, 2016 / Notices inimical to the common defense and security or to the health and safety of the public. Finally, the NRC finds that the findings required by Subpart A of 10 CFR part 51 have been made. Accordingly, the immediately effective construction permit was issued on February 29, 2016. II. Further Information The NRC prepared a Safety Evaluation Report (SER) and Final Environmental Impact Statement (FEIS) that document the information reviewed and the NRC’s conclusion. The Commission also issued its Memorandum and Order documenting its final decision on the mandatory hearing held on December 15, 2015, which serves as the ROD in this proceeding. The NRC also prepared a document summarizing the ROD to accompany its action on the construction permit application that incorporates by reference materials contained in the FEIS. In accordance with 10 CFR 2.390 of the NRC’s ‘‘Agency Rules of Practice and Procedure,’’ details with respect to this action, including the SER, FEIS, summary of the ROD, and accompanying documentation included in the construction permit package, as well as the Commission’s hearing decision and ROD, are available online in the ADAMS Public Documents collection at https://www.nrc.gov/ reading-rm/adams.html. From this site, persons can access the NRC’s ADAMS, which provides text and image files of NRC’s public documents. III. Availability of Documents The documents identified in the following table are available to interested persons through one or more of the following methods, as indicated. ADAMS Accession No. Document Construction Permit No. CPMIF–001 ............................................................................................................................................... Commission’s Memorandum and Order on the mandatory hearing (ROD) .................................................................................... Summary of the Record of Decision ................................................................................................................................................ Safety Evaluation Report Related to the SHINE Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility. NUREG–2183, Final Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility. SHINE Construction Permit Application ........................................................................................................................................... Dated at Rockville, Maryland, this 29 day of February 2016. For the Nuclear Regulatory Commission. Lawrence E. Kokajko, Director, Division of Policy and Rulemaking, Office of Nuclear Reactor Regulation. [FR Doc. 2016–04864 Filed 3–3–16; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION [Docket Nos. 52–022 and 52–023; NRC– 2013–0261] Duke Energy Progress; Combined License Applications for Shearon Harris Nuclear Plant Units 2 and 3 Nuclear Regulatory Commission. ACTION: Exemption; issuance. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) is issuing an exemption in response to an August 12, 2015, letter from Duke Energy Progress (DEP). On May 2, 2013, DEP requested that the NRC suspend review of its combined license (COL) application until further notice. On August 12, 2015, DEP requested an exemption from certain regulatory requirements which, if granted, would allow them to revise their COL application in order to address enhancements to the Emergency Preparedness (EP) rules by December 31, 2016, rather than by December 31, jstallworth on DSK7TPTVN1PROD with NOTICES SUMMARY: VerDate Sep<11>2014 15:22 Mar 03, 2016 Jkt 238001 2013, as the regulations currently require. The NRC staff reviewed this request and determined that it is appropriate to grant the exemption to the EP update requirements until December 31, 2016, but stipulated that the updates to the Final Safety Analysis Report (FSAR) must be submitted prior to requesting the NRC resume its review of the COL application, or by December 31, 2016, whichever comes first. DATES: The exemption is effective on March 4, 2016. ADDRESSES: Please refer to Docket ID NRC–2013–0261 when contacting the NRC about the availability of information regarding this document. You may obtain publicly-available information related to this document using any of the following methods: • Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC–2013–0261. Address questions about NRC dockets to Carol Gallagher; telephone: 301–415–3463; email: Carol.Gallagher@nrc.gov. For technical questions, contact the individuals listed in the FOR FURTHER INFORMATION CONTACT section of this document. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publiclyavailable documents online in the ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘ADAMS Public Documents’’ and then PO 00000 Frm 00094 Fmt 4703 Sfmt 4703 ML16041A471 ML16056A094 ML16041A470 ML15342A396 ML15288A046 ML13088A192 ML15259A272 ML15258A431 select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301–415–4737, or by email to pdr.resource@nrc.gov. The ADAMS accession number for each document referenced (if it available in ADAMS) is provided the first time that a document is referenced. • NRC’s PDR: You may examine and purchase copies of public documents at the NRC’s PDR, Room O1–F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. FOR FURTHER INFORMATION CONTACT: Brian Hughes, Office of New Reactors, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001; telephone: 301–415–6582; email: Brian.Hughes@ nrc.gov. SUPPLEMENTARY INFORMATION: I. Background On February 18, 2008, (ADAMS Accession No. ML080580078) DEP submitted to the NRC a COL application for two units of Westinghouse Electric Company’s AP1000 advanced pressurized water reactors to be constructed and operated at the existing Shearon Harris Nuclear Plant (Harris) site (Docket Numbers 052000–22 and 052000–23). The NRC docketed the Harris Units 2 and 3 COL application on April 23, 2008. On May 2, 2013 (ADAMS Accession No. ML13123A344), E:\FR\FM\04MRN1.SGM 04MRN1

Agencies

[Federal Register Volume 81, Number 43 (Friday, March 4, 2016)]
[Notices]
[Pages 11600-11601]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-04864]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[Docket No. 50-608; NRC-2013-0053]


SHINE Medical Technologies, Inc.; SHINE Medical Isotope Facility

AGENCY: Nuclear Regulatory Commission.

ACTION: Construction permit and record of decision; issuance.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is providing 
notice of the issuance of Construction Permit CPMIF-001 to SHINE 
Medical Technologies, Inc. (SHINE) and record of decision, located in 
Janesville, Wisconsin.

ADDRESSES: Please refer to Docket ID NRC-2013-0053 when contacting the 
NRC about the availability of information regarding this document. You 
may obtain publicly-available information related to this document 
using any of the following methods:
     Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC-2013-0053. Address 
questions about NRC dockets to Carol Gallagher; telephone: 301-415-
3463; email: Carol.Gallagher@nrc.gov. For technical questions, contact 
the individual listed in the FOR FURTHER INFORMATION CONTACT section of 
this document.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly-available documents online in the 
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and 
then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS, 
please contact the NRC's Public Document Room (PDR) reference staff at 
1-800-397-4209, 301-415-4737, or by email to pdr.resource@nrc.gov. For 
the convenience of the reader, the ADAMS accession numbers are provided 
in a table in the ``Availability of Documents'' section of this 
document.
     NRC's PDR: You may examine and purchase copies of public 
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555 
Rockville Pike, Rockville, Maryland 20852.

FOR FURTHER INFORMATION CONTACT: Steven Lynch, Office of Nuclear 
Reactor Regulation, U.S. Nuclear Regulatory Commission, Washington, DC 
20555-0001; telephone: 301-415-1524, email: Steven.Lynch@nrc.gov.

SUPPLEMENTARY INFORMATION:

I. Introduction

    Under section 2.106 of title 10 of the Code of Federal Regulations 
(10 CFR), the NRC is providing notice of the issuance of Construction 
Permit, CPMIF-001 to SHINE and, issuance of the Record of Decision 
(ROD) under 10 CFR 51.102(c). The construction permit, which is 
immediately effective, authorizes SHINE to construct a facility that 
will house eight utilization facilities and one production facility 
designed for the production of medical radioisotopes, as described in 
SHINE's application for construction permit, in Janesville, Wisconsin. 
With respect to the application for the construction permit filed by 
SHINE, the NRC finds that the applicable standards and requirements of 
the Atomic Energy Act of 1954, as amended (the Act), and the 
Commission's regulations have been met. The NRC finds that any required 
notifications to other agencies or bodies have been duly made and that, 
among other things, there is reasonable assurance that the activities 
authorized by the permit will be conducted in compliance with the rules 
and regulations of the Commission, that safety questions will be 
satisfactorily resolved by the completion of construction, and that, 
taking into consideration siting criteria, the proposed facility can be 
constructed and operated at the proposed location without under risk to 
public health and safety, subject to the conditions listed in the 
construction permit. Furthermore, the NRC finds that the licensee is 
technically and financially qualified to engage in the activities 
authorized, and that issuance of the license will not be

[[Page 11601]]

inimical to the common defense and security or to the health and safety 
of the public. Finally, the NRC finds that the findings required by 
Subpart A of 10 CFR part 51 have been made.
    Accordingly, the immediately effective construction permit was 
issued on February 29, 2016.

II. Further Information

    The NRC prepared a Safety Evaluation Report (SER) and Final 
Environmental Impact Statement (FEIS) that document the information 
reviewed and the NRC's conclusion. The Commission also issued its 
Memorandum and Order documenting its final decision on the mandatory 
hearing held on December 15, 2015, which serves as the ROD in this 
proceeding. The NRC also prepared a document summarizing the ROD to 
accompany its action on the construction permit application that 
incorporates by reference materials contained in the FEIS. In 
accordance with 10 CFR 2.390 of the NRC's ``Agency Rules of Practice 
and Procedure,'' details with respect to this action, including the 
SER, FEIS, summary of the ROD, and accompanying documentation included 
in the construction permit package, as well as the Commission's hearing 
decision and ROD, are available online in the ADAMS Public Documents 
collection at https://www.nrc.gov/reading-rm/adams.html. From this site, 
persons can access the NRC's ADAMS, which provides text and image files 
of NRC's public documents.

III. Availability of Documents

    The documents identified in the following table are available to 
interested persons through one or more of the following methods, as 
indicated.

------------------------------------------------------------------------
                Document                       ADAMS  Accession No.
------------------------------------------------------------------------
Construction Permit No. CPMIF-001.......  ML16041A471
Commission's Memorandum and Order on the  ML16056A094
 mandatory hearing (ROD).
Summary of the Record of Decision.......  ML16041A470
Safety Evaluation Report Related to the   ML15342A396
 SHINE Medical Technologies, Inc.
 Construction Permit Application for a
 Medical Radioisotope Production
 Facility.
NUREG-2183, Final Environmental Impact    ML15288A046
 Statement for the Construction Permit
 for the SHINE Medical Radioisotope
 Production Facility.
SHINE Construction Permit Application...  ML13088A192
                                          ML15259A272
                                          ML15258A431
------------------------------------------------------------------------


    Dated at Rockville, Maryland, this 29 day of February 2016.

    For the Nuclear Regulatory Commission.
Lawrence E. Kokajko,
Director, Division of Policy and Rulemaking, Office of Nuclear Reactor 
Regulation.
[FR Doc. 2016-04864 Filed 3-3-16; 8:45 am]
BILLING CODE 7590-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.